Status:
COMPLETED
Prognostic Value of a Positive RT-PCR Test in Patients With Ewing Sarcoma
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Non-Metastatic Ewings Sarcoma
Eligibility:
All Genders
2-30 years
Brief Summary
This study will determine whether the results of a test called reverse transcriptase-polymerase chain reaction (RT-PCR) correlate with clinical outcomes in patients with Ewing sarcoma, and if they can...
Detailed Description
BACKGROUND: Clinical evidence for metastatic disease at the time of diagnosis is an indicator of poor prognosis in Ewing's sarcoma. Patients with non-metastatic disease at presentation are thought to ...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Patients enrolled on COG AEWS0031 are eligible for this study.
- EXCLUSION CRITERIA:
- Patients who were enrolled but from whom samples were not obtained will not be enrolled on this study.
Exclusion
Key Trial Info
Start Date :
March 12 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 13 2015
Estimated Enrollment :
414 Patients enrolled
Trial Details
Trial ID
NCT00339898
Start Date
March 12 2004
End Date
January 13 2015
Last Update
December 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute (NCI), 9000 Rockville Pike
Bethesda, Maryland, United States, 20892